Analysis of exhaled breath for screening of lung cancer patients

Memo - Magazine of European Medical Oncology

Volumn 3, Issue 3, 2010, Pages 106-112

  Amann, A ^a,b   Ligor, M ^a,c   Ligor, T ^a,c   Bajtarevic, A ^a,b   Ager, C ^a,b   Pienz, M ^a,b   Denz, H ^a,d   Fiegl, M ^a,e   Hilbe, W ^e   Weiss, W ^b   Lukas, P ^b   Jamnig, H ^d   Hackl, M ^d   Haidenberger, A ^f   Sponring, A ^a,b   Filipiak, W ^a,b   Miekisch, W ^a,g   Schubert, J ^a,g   Troppmair, J ^b   Buszewski, B ^a,c  

^a ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^d Landeskrankenhaus Natters   (Austria)

^e INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^f Institution of Radio Oncology   (Austria)

^g UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Exhaled breath analysis; Gas chromatography mass spectrometry; Lung cancer; Proton transfer reaction mass spectrometry; Volatile organic compounds

Indexed keywords

FLUOROURACIL; VOLATILE ORGANIC COMPOUND;

BREATH ANALYSIS; CANCER CELL; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SCREENING; DIAGNOSTIC VALUE; DRUG ANALYSIS; DRUG METABOLISM; EXHALATION; EXPIRED AIR; GAS ANALYSIS; HUMAN; LUNG CANCER; NON INVASIVE MEASUREMENT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; SMOKING;

EID: 78649643869     PISSN: 18655041     EISSN: 18655076     Source Type: Journal    
DOI: 10.1007/s12254-010-0219-2     Document Type: Review

References (43)

1. II Wistuba AF Gazdar JD Minna 2001 Molecular genetics of small cell lung carcinoma Semin Oncol 28 2 Suppl 4 3 13 1:CAS:528:DC%2BD3MXmsVyktbw%3D 10.1053/sonc.2001.25738 11479891
2. M Sato DS Shames AF Gazdar JD Minna 2007 A translational view of the molecular pathogenesis of lung cancer J Thorac Oncol 2 4 327 343 10.1097/01.JTO.0000263718.69320.4c 17409807 (Pubitemid 47181718)
3. A Risch C Plass 2008 Lung cancer epigenetics and genetics Int J Cancer 123 1 1 7 1:CAS:528:DC%2BD1cXmtlantrs%3D 10.1002/ijc.23605 18425819 (Pubitemid 351705185)
4. CI Henschke DF Yankelevitz DM Libby MW Pasmantier JP Smith OS Miettinen 2006 Survival of patients with stage I lung cancer detected on CT screening N Engl J Med 355 17 1763 1771 10.1056/NEJMoa060476 17065637 (Pubitemid 44631359)
5. M Infante S Cavuto FR Lutman G Brambilla G Chiesa G Ceresoli E Passera E Angeli M Chiarenza G Aranzulla U Cariboni V Errico F Inzirillo E Bottoni E Voulaz M Alloisio A Destro M Roncalli A Santoro G Ravasi 2009 A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial Am J Respir Crit Care Med 180 5 445 453 10.1164/rccm.200901-0076OC 19520905
6. PB Bach JR Jett U Pastorino MS Tockman SJ Swensen CB Begg 2007 Computed tomography screening and lung cancer outcomes Jama 297 9 953 961 1:CAS:528:DC%2BD2sXisFKns7k%3D 10.1001/jama.297.9.953 17341709 (Pubitemid 46376749)
7. A Bajtarevic C Ager M Pienz M Klieber K Schwarz M Ligor T Ligor W Filipiak H Denz M Fiegl W Hilbe W Weiss P Lukas H Jamnig M Hackl A Haidenberger B Buszewski W Miekisch J Schubert A Amann 2009 Noninvasive detection of lung cancer by analysis of exhaled breath BMC Cancer 9 1 348 10.1186/1471-2407-9-348 19788722
8. M Ligor T Ligor A Bajtarevic C Ager M Pienz M Klieber H Denz M Fiegl W Hilbe W Weiss P Lukas H Jamnig M Hackl B Buszewski W Miekisch J Schubert A Amann 2009 Determination of volatile organic compounds appearing in exhaled breath of lung cancer patients by solid phase microextraction and gas chromatography mass spectrometry Clin Chem Lab Med 47 550 560 1:CAS:528:DC%2BD1MXntFajsLs%3D 10.1515/CCLM.2009.133 19397483
9. M Phillips RN Cataneo C Saunders P Hope P Schmitt J Wai 2010 Volatile biomarkers in the breath of women with breast cancer J Breath Res 4 2 026003 10.1088/1752-7155/4/2/026003
10. W Miekisch JK Schubert GF Noeldge-Schomburg 2006 From highly sophisticated analytical techniques to life-saving diagnostics: technical developments in breath analysis Trends in Anal Chem 25 7 665 673 1:CAS:528:DC%2BD28XnsFOms7s%3D 10.1016/j.trac.2006.05.006 (Pubitemid 44093743)
11. A Amann P Spanel D Smith 2007 Breath analysis: the approach towards clinical applications Mini Rev Med Chem 7 115 129 1:CAS:528:DC%2BD2sXitlamt70%3D 10.2174/138955707779802606 17305586 (Pubitemid 46592175)
12. D Poli P Carbognani M Corradi M Goldoni O Acampa B Balbi L Bianchi M Rusca A Mutti 2005 Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study Respir Res 6 1 71 10.1186/1465-9921-6-71 16018807 (Pubitemid 41410164)
13. J Schubert W Miekisch T Birken K Geiger G Nöldge-Schomburg 2005 Impact of inspired substance concentrations onto results of breath analysis in mechanically ventilated patients Biomarkers 10 138 152 1:CAS:528: DC%2BD2MXlslOms7g%3D 10.1080/13547500500050259 16076729 (Pubitemid 40916672)
14. Schubert J, Miekisch W, Nöldge-Schomburg G. VOC breath markers in critically ill patients: potentials and limitations. In: Amann A, Smith D (eds) Breath analysis for clinical diagnosis and therapeutic monitoring. World Scientific, Singapore, pp. 267-292, 2005
15. JK Schubert W Miekisch K Geiger GF Noldge-Schomburg 2004 Breath analysis in critically ill patients: potential and limitations Expert Rev Mol Diagn 4 5 619 629 1:CAS:528:DC%2BD2cXosVWgsb0%3D 10.1586/14737159.4.5.619 15347256 (Pubitemid 39220837)
16. W Miekisch JK Schubert GF Noeldge-Schomburg 2004 Diagnostic potential of breath analysis - focus on volatile organic compounds Clin Chim Acta 347 1-2 25 39 1:CAS:528:DC%2BD2cXmslensL0%3D 10.1016/j.cccn.2004.04.023 15313139 (Pubitemid 39099603)
17. T Ligor M Ligor A Amann C Ager M Bachler A Dzien B Buszewski 2008 The analysis of healthy volunteers' exhaled breath by the use of solid-phase microextraction and GC-MS J Breath Res 2 046006 10.1088/1752-7155/2/4/046006
18. J Herbig M Müller S Schallhart T Titzmann M Graus A Hansel 2009 On-line breath analysis with PTR-TOF J Breath Res 3 027004 10.1088/1752-7155/3/ 2/027004 (10pp)
19. J King A Kupferthaler K Unterkofler H Koc S Teschl W Miekisch J Schubert H Hitnerhuber A Amann 2009 Isoprene and acetone concentration profiles during exercise at an ergometer J Breath Res 3 027006 10.1088/1752-7155/3/2/027006 (16pp)
20. J King P Mochalski A Kupferthaler K Unterkofler W Filipiak S Teschl G Teschl H Hinterhuber A Amann 2010 Dynamic profiles of volatile organic compounds in exhaled breath as determined by a coupled PTR-MS/GC-MS study Physiol Meas 31 9 1169 1184 1:STN:280:DC%2BC3cjktV2gsg%3D%3D 10.1088/0967-3334/31/9/008 20664160
21. D Smith P Spanel 2005 Selected ion flow tube mass spectrometry (SIFT-MS) for on-line trace gas analysis Mass Spectrom Rev 24 5 661 700 1:CAS:528:DC%2BD2MXhtVahs7fM 10.1002/mas.20033 15495143 (Pubitemid 41615714)
22. V Ruzsanyi JI Baumbach S Sielemann P Litterst M Westhoff L Freitag 2005 Detection of human metabolites using multi-capillary columns coupled to ion mobility spectrometers J Chromatogr A 1084 1-2 145 151 1:CAS:528: DC%2BD2MXmt1Wjsbw%3D 10.1016/j.chroma.2005.01.055 16114247 (Pubitemid 40966921)
23. JI Baumbach 2009 Ion mobility spectrometry coupled with multi-capillary columns for metabolic profiling of human breath J Breath Res 3 034001 10.1088/1752-7155/3/3/034001
24. von Basum G, Halmer D, Hering P, Mürtz M. Laser spectroscopic on-line monitoring of exhaled trace gases. In: Amann A, Smith D, (eds) Breath analysis for clinical diagnosis and therapeutic monitoring. World Scientific, Singapore, pp. 67-74, 2005
25. Wysocki G, McCurdy M, So S, Roller C, Tittel F. Exhaled human breath analysis with quantum cascade laser-based gas sensors. In: Amann A, Smith D (eds) Breath analysis for clinical diagnosis and therapeutic monitoring. World Scientific, Singapore, pp. 75-84, 2005
26. T Fritsch P Hering M Murtz 2007 Infrared laser spectrosopy for online recording of exhaled carbon monoxide - a progress report J Breath Res 1 1 014002 10.1088/1752-7155/1/1/014002
27. Amann A, Telser S, Hofer L, Schmid A, Hinterhuber H. Breath gas as a biochemical probe in sleeping individuals. In: Amann A, Smith D (eds) Breath analysis for clinical diagnosis and therapeutic monitoring. World Scientific, Singapore, pp. 305-316, 2005
28. Dweik R. Nitric oxide in exhaled breath: a window on lung physiology and pulmonary disease. In: Amann A, Smith D (eds) Breath analysis for clinical diagnosis and therapeutic monitoring. World Scientific, Singapore, 2005
29. Gustafsson L. Exhaled nitric oxide: how and why we know it is important. In: Amann A, Smith D (eds) Breath analysis for clinical diagnosis and therapeutic monitoring. World Scientific, Singapore, 2005
30. Lundberg J. Nasal nitric oxide measurements as a diagnostic tool: ready for clinical use?. In: Amann A, Smith D, (eds) Breath analysis for clinical diagnosis and therapeutic monitoring. World Scientific, Singapore, 2005
31. JO Lundberg M Maniscalco M Sofia L Lundblad E Weitzberg M Maniscalo 2003 Humming, nitric oxide, and paranasal sinus obstruction Jama 289 3 302 303 10.1001/jama.289.3.302-b 12525230 (Pubitemid 36083981)
32. Kischkel S, Miekisch W, Sawacki A, Straker EM, Trefz P, Amann A, Schubert JK. Breath biomarkers for lung cancer detection and assessment of smoking related effects - confounding variables, influence of normalization and statistical algorithms. Clin Chim Acta, 2010: to appear
33. LK Mattison H Ezzeldin M Carpenter A Modak MR Johnson RB Diasio 2004 Rapid identification of dihydropyrimidine dehydrogenase deficiency by using a novel 2-13C-uracil breath test Clin Cancer Res 10 8 2652 2658 1:CAS:528:DC%2BD2cXjt1Clt7g%3D 10.1158/1078-0432.CCR-03-0374 15102667 (Pubitemid 38509138)
34. HH Ezzeldin EP Acosta LK Mattison J Fourie A Modak RB Diasio 2009 13C-5-FU breath test current status and future directions: a comprehensive review J Breath Res 3 4 047002 10.1088/1752-7155/3/4/047002
35. AS Modak 2010 Single time point diagnostic breath tests: a review J Breath Res 4 1 017002 10.1088/1752-7155/4/1/017002
36. A Sponring W Filipiak T Mikoviny C Ager J Schubert W Miekisch A Amann J Troppmair 2009 Release of volatile organic compounds from the lung cancer cell line NCI-H2087 in vitro Anticancer Res 29 1 419 426 1:CAS:528: DC%2BD1MXjtFGgt70%3D 19331181
37. W Filipiak A Sponring T Mikoviny C Ager J Schubert W Miekisch A Amann J Troppmair 2008 Release of volatile organic compounds (VOCs) from the lung cancer cell line CALU-1 in vitro Cancer Cell Int 8 1 17 10.1186/1475-2867-8-17 19025629
38. W Filipiak A Sponring A Filipiak C Ager J Schubert W Miekisch A Amann J Troppmair 2010 TD-GC-MS analysis of volatile metabolites of human lung cancer and normal cells in vitro Cancer Epidemiol Biomarkers Prev 19 1 182 195 1:CAS:528:DC%2BC3cXhvFegug%3D%3D 10.1158/1055-9965.EPI-09-0162 20056637
39. ZJ Reitman NJ Olby CL Mariani R Thomas M Breen DD Bigner RE McLendon H Yan 2010 IDH1 and IDH2 hotspot mutations are not found in canine glioma Int J Cancer 127 1 245 246 1:CAS:528:DC%2BC3cXlsVOrsbw%3D 19877121
40. ZJ Reitman DW Parsons H Yan 2010 IDH1 and IDH2: not your typical oncogenes Cancer Cell 17 3 215 216 1:CAS:528:DC%2BC3cXlsVWqtLw%3D 10.1016/j.ccr.2010.02.024 20227034
41. JV Castell MT Donato MJ Gomez-Lechon 2005 Metabolism and bioactivation of toxicants in the lung. The in vitro cellular approach Exp Toxicol Pathol 57 Suppl 1 189 204 1:CAS:528:DC%2BD2MXhtVGmsbbF 10.1016/j.etp.2005.05.008 16092727 (Pubitemid 40884492)
42. T Kamataki K Nunoya Y Sakai H Kushida K Fujita 1999 Genetic polymorphism of CYP2A6 in relation to cancer Mutat Res 428 1-2 125 130 1:CAS:528: DyaK1MXltlCqs7Y%3D 10517986
43. A Lippi L Citti P Gervasi G Turchi G Bellucci E Mastrorilli 1983 Metabolism of 1,3-cyclohexadiene by isolated rat liver cells Toxicology 28 1-2 93 101 1:CAS:528:DyaL2cXks1Cktw%3D%3D 10.1016/0300-483X(83)90109-9 6636203